BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 23410123)

  • 1. Sirtuins as possible targets in neurodegenerative diseases.
    Donmez G
    Curr Drug Targets; 2013 Jun; 14(6):644-7. PubMed ID: 23410123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SIRT1 and SIRT2: emerging targets in neurodegeneration.
    Donmez G; Outeiro TF
    EMBO Mol Med; 2013 Mar; 5(3):344-52. PubMed ID: 23417962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sirtuins and Their Roles in Brain Aging and Neurodegenerative Disorders.
    Jęśko H; Wencel P; Strosznajder RP; Strosznajder JB
    Neurochem Res; 2017 Mar; 42(3):876-890. PubMed ID: 27882448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neurobiology of sirtuins and their role in neurodegeneration.
    Donmez G
    Trends Pharmacol Sci; 2012 Sep; 33(9):494-501. PubMed ID: 22749331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirtuins: common targets in aging and in neurodegeneration.
    de Oliveira RM; Pais TF; Outeiro TF
    Curr Drug Targets; 2010 Oct; 11(10):1270-80. PubMed ID: 20840069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dichotomous Sirtuins: Implications for Drug Discovery in Neurodegenerative and Cardiometabolic Diseases.
    Gomes P; Leal H; Mendes AF; Reis F; Cavadas C
    Trends Pharmacol Sci; 2019 Dec; 40(12):1021-1039. PubMed ID: 31704173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SIRTUIN 1: regulating the regulator.
    Zschoernig B; Mahlknecht U
    Biochem Biophys Res Commun; 2008 Nov; 376(2):251-5. PubMed ID: 18774777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer agents targeted to sirtuins.
    Kozako T; Suzuki T; Yoshimitsu M; Arima N; Honda S; Soeda S
    Molecules; 2014 Dec; 19(12):20295-313. PubMed ID: 25486244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sirtuin deacetylases in neurodegenerative diseases of aging.
    Herskovits AZ; Guarente L
    Cell Res; 2013 Jun; 23(6):746-58. PubMed ID: 23689277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sirtuin-targeting drugs: Mechanisms of action and potential therapeutic applications.
    Aljada A; Dong L; Mousa SA
    Curr Opin Investig Drugs; 2010 Oct; 11(10):1158-68. PubMed ID: 20872319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sirtuins in neurodegenerative diseases: a biological-chemical perspective.
    Raghavan A; Shah ZA
    Neurodegener Dis; 2012; 9(1):1-10. PubMed ID: 22041967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SIRT1 and SIRT2 Activity Control in Neurodegenerative Diseases.
    Manjula R; Anuja K; Alcain FJ
    Front Pharmacol; 2020; 11():585821. PubMed ID: 33597872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seven sirtuins for seven deadly diseases of aging.
    Morris BJ
    Free Radic Biol Med; 2013 Mar; 56():133-71. PubMed ID: 23104101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylases as targets for the treatment of human neurodegenerative diseases.
    D'Mello SR
    Drug News Perspect; 2009 Nov; 22(9):513-24. PubMed ID: 20072728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Sirtuin family: therapeutic targets to treat diseases of aging.
    Milne JC; Denu JM
    Curr Opin Chem Biol; 2008 Feb; 12(1):11-7. PubMed ID: 18282481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sirtuin Acetylation and Deacetylation: a Complex Paradigm in Neurodegenerative Disease.
    Khan H; Tiwari P; Kaur A; Singh TG
    Mol Neurobiol; 2021 Aug; 58(8):3903-3917. PubMed ID: 33877561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sirtuin activators and inhibitors.
    Villalba JM; Alcaín FJ
    Biofactors; 2012; 38(5):349-59. PubMed ID: 22730114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of NAD+ dependent histone deacetylases (sirtuins).
    Neugebauer RC; Sippl W; Jung M
    Curr Pharm Des; 2008; 14(6):562-73. PubMed ID: 18336301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sirtuins and Their Implications in Neurodegenerative Diseases from a Drug Discovery Perspective.
    Yeong KY; Berdigaliyev N; Chang Y
    ACS Chem Neurosci; 2020 Dec; 11(24):4073-4091. PubMed ID: 33280374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the Role of Histone Deacetylase and their Inhibitors in Neurodegenerative Disorders: Current Targets and Future Perspective.
    Kumar V; Kundu S; Singh A; Singh S
    Curr Neuropharmacol; 2022; 20(1):158-178. PubMed ID: 34151764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.